🍪 Our Cookies

This website uses cookies, pixel tags, and similar technologies (“Cookies”) for the purpose of enabling site operations and for performance, personalisation, and marketing purposes. We use our own Cookies and some from third parties. Only essential Cookies are used by default. By clicking “Accept All” you consent to the use of non-essential Cookies (i.e., functional, analytics, and marketing Cookies) and the related processing of personal data. You can manage your consent preferences by clicking Manage Preferences. You may withdraw a consent at any time by using the link “Cookie Preferences” in the footer of our website.

Our Privacy Notice is accessible here. To learn more about the use of Cookies on our website, please view our Cookie Notice.

Private credit preps $9bn Hologic financing to rival BSL offering for LBO

Share

News and Analysis

Private credit preps $9bn Hologic financing to rival BSL offering for LBO

Shubham Saharan's avatar
Bill Weisbrod's avatar
David Brooke's avatar
  1. Shubham Saharan
  2. +Bill Weisbrod
  3. + 1 more
•1 min read

Don’t miss out on news you won’t find anywhere else — get The Memo US and The Memo Europe in your inbox every two weeks.

Direct lenders are preparing a $9bn debt financing package in an attempt to compete with banks to back Blackstone and TPG’s bid for Hologic, according to 9fin sources.

The private credit package would include a roughly $9bn unitranche priced in the range of SOFR+475bps, the sources said. Lenders looking to provide the financing include Apollo, Blackstone Credit, Golub and HPS, they added.

Meanwhile, as a competing package, banks have lined up $10bn of financing split between first lien and second lien broadly syndicated loans. 9fin reported earlier this month on the potential structure of the deal. Sources familiar provided more detail on this separate BSL package, and added that the second lien portion would be $1bn in size, and priced in a range of SOFR+475bps to SOFR+500bps.

Hologic is a manufacturer and developer of women’s health diagnostic devices. Blackstone and TPG’s first $16bn bid for the company was rejected earlier this year. The firms reopened talks for a take-private in September.

Blackstone and TPG declined to comment. Apollo, Golub, Hologic and HPS did not respond to requests for comment.

What are you waiting for?

Try it out
  • We're trusted by the top 10 Investment Banks